Literature DB >> 21922329

Mechanism-based population modelling for assessment of L-cell function based on total GLP-1 response following an oral glucose tolerance test.

Jonas B Møller1, William J Jusko, Wei Gao, Torben Hansen, Oluf Pedersen, Jens J Holst, Rune V Overgaard, Henrik Madsen, Steen H Ingwersen.   

Abstract

GLP-1 is an insulinotropic hormone that synergistically with glucose gives rise to an increased insulin response. Its secretion is increased following a meal and it is thus of interest to describe the secretion of this hormone following an oral glucose tolerance test (OGTT). The aim of this study was to build a mechanism-based population model that describes the time course of total GLP-1 and provides indices for capability of secretion in each subject. The goal was thus to model the secretion of GLP-1, and not its effect on insulin production. Single 75 g doses of glucose were administered orally to a mixed group of subjects ranging from healthy volunteers to patients with type 2 diabetes (T2D). Glucose, insulin, and total GLP-1 concentrations were measured. Prior population data analysis on measurements of glucose and insulin were performed in order to estimate the glucose absorption rate. The individual estimates of absorption rate constants were used in the model for GLP-1 secretion. Estimation of parameters was performed using the FOCE method with interaction implemented in NONMEM VI. The final transit/indirect-response model obtained for GLP-1 production following an OGTT included two stimulation components (fast, slow) for the zero-order production rate. The fast stimulation was estimated to be faster than the glucose absorption rate, supporting the presence of a proximal-distal loop for fast secretion from L: -cells. The fast component (st₃) = 8.64·10⁻⁵ [mg⁻¹]) was estimated to peak around 25 min after glucose ingestion, whereas the slower component (st₄ = 26.2·10⁻⁵ [mg⁻¹]) was estimated to peak around 100 min. Elimination of total GLP-1 was characterised by a first-order loss. The individual values of the early phase GLP-1 secretion parameter (st₃) were correlated (r = 0.52) with the AUC(0-60 min.) for GLP-1. A mechanistic population model was successfully developed to describe total GLP-1 concentrations over time observed after an OGTT. The model provides indices related to different mechanisms of subject abilities to secrete GLP-1. The model provides a good basis to study influence of different demographic factors on these components, presented mainly by indices of the fast- and slow phases of GLP-1 response.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21922329      PMCID: PMC3407884          DOI: 10.1007/s10928-011-9216-2

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  24 in total

1.  Diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

2.  Minimal model estimation of glucose absorption and insulin sensitivity from oral test: validation with a tracer method.

Authors:  Chiara Dalla Man; Andrea Caumo; Rita Basu; Robert Rizza; Gianna Toffolo; Claudio Cobelli
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-05-11       Impact factor: 4.310

3.  Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men.

Authors:  E Rask; T Olsson; S Söderberg; O Johnson; J Seckl; J J Holst; B Ahrén
Journal:  Diabetes Care       Date:  2001-09       Impact factor: 19.112

4.  Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients.

Authors:  M B Toft-Nielsen; M B Damholt; S Madsbad; L M Hilsted; T E Hughes; B K Michelsen; J J Holst
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

5.  Predictive performance for population models using stochastic differential equations applied on data from an oral glucose tolerance test.

Authors:  Jonas B Møller; Rune V Overgaard; Henrik Madsen; Torben Hansen; Oluf Pedersen; Steen H Ingwersen
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-12-16       Impact factor: 2.745

6.  An integrated glucose-insulin model to describe oral glucose tolerance test data in healthy volunteers.

Authors:  Hanna E Silber; Nicolas Frey; Mats O Karlsson
Journal:  J Clin Pharmacol       Date:  2009-11-25       Impact factor: 3.126

7.  Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance.

Authors:  E Rask; T Olsson; S Söderberg; J j Holst Jj; A Tura; G Pacini; B Ahrén
Journal:  Metabolism       Date:  2004-05       Impact factor: 8.694

8.  Modeling the metabolic effects of terbutaline in beta2-adrenergic receptor diplotypes.

Authors:  John J Lima; Nobuko Matsushima; Niranjan Kissoon; Jianwei Wang; James E Sylvester; William J Jusko
Journal:  Clin Pharmacol Ther       Date:  2004-07       Impact factor: 6.875

9.  Similar elimination rates of glucagon-like peptide-1 in obese type 2 diabetic patients and healthy subjects.

Authors:  T Vilsbøll; H Agersø; T Krarup; J J Holst
Journal:  J Clin Endocrinol Metab       Date:  2003-01       Impact factor: 5.958

10.  Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects.

Authors:  Juris J Meier; Michael A Nauck; Daniel Kranz; Jens J Holst; Carolyn F Deacon; Dirk Gaeckler; Wolfgang E Schmidt; Baptist Gallwitz
Journal:  Diabetes       Date:  2004-03       Impact factor: 9.461

View more
  6 in total

1.  Role of vesicle-associated membrane protein 2 in exocytosis of glucagon-like peptide-1 from the murine intestinal L cell.

Authors:  Samantha K Li; Dan Zhu; Herbert Y Gaisano; Patricia L Brubaker
Journal:  Diabetologia       Date:  2013-12-20       Impact factor: 10.122

Review 2.  Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.

Authors:  Robert E Steinert; Christine Feinle-Bisset; Lori Asarian; Michael Horowitz; Christoph Beglinger; Nori Geary
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

3.  Influence of sucrose ingestion on brainstem and hypothalamic intrinsic oscillations in lean and obese women.

Authors:  Lisa A Kilpatrick; Kristen Coveleskie; Lynn Connolly; Jennifer S Labus; Bahar Ebrat; Jean Stains; Zhiguo Jiang; Brandall Y Suyenobu; Helen E Raybould; Kirsten Tillisch; Emeran A Mayer
Journal:  Gastroenterology       Date:  2014-01-28       Impact factor: 22.682

4.  The SNARE Protein Syntaxin-1a Plays an Essential Role in Biphasic Exocytosis of the Incretin Hormone Glucagon-Like Peptide 1.

Authors:  Sarah E Wheeler; Holly M Stacey; Yasaman Nahaei; Stephen J Hale; Alexandre B Hardy; Frank Reimann; Fiona M Gribble; Pierre Larraufie; Herbert Y Gaisano; Patricia L Brubaker
Journal:  Diabetes       Date:  2017-06-08       Impact factor: 9.461

Review 5.  Glucagon-like peptide-1: The missing link in the metabolic clock?

Authors:  Patricia L Brubaker; Manuel Gil-Lozano
Journal:  J Diabetes Investig       Date:  2016-03-14       Impact factor: 4.232

6.  Glucagon-Like Peptide-1 (GLP-1) Treatment Ameliorates Cognitive Impairment by Attenuating Arc Expression in Type 2 Diabetic Rats.

Authors:  Xiang-Sheng Cai; Zhao-Guang Tan; Jing-Jing Li; Wei-Hong Gao; Shu-Ji Li; Jin-Long Li; Yong-Ming Tang; Hong-Wei Li; Hong-Xiang Hui
Journal:  Med Sci Monit       Date:  2017-09-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.